Testing a New Method to Diagnose a Common Cause of High Blood Pressure
Part of Hormones & metabolism clinical trials.
This study uses a new, precise blood test to help diagnose primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. It compares results from healthy volunteers and patients with suspected primary aldosteronism to see if it works better than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- For healthy volunteers: your blood pressure is between 100-120/60-80 mmHg and you have no history of high blood pressure.
- For patients with suspected primary aldosteronism: your doctor suspects you have this condition and you are willing to take spironolactone for 4 weeks.
- Your body mass index (BMI) is between 18.5 and 23.9 if you are a healthy volunteer.
- You have no history of liver or kidney problems, heart disease, diabetes (if poorly controlled), or certain other illnesses.
- You are not taking medicines that affect the renin-angiotensin system (like some contraceptives, steroids, or diabetes drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is developing a better blood test to diagnose primary aldosteronism, a condition where the adrenal glands produce too much of a hormone called aldosterone, causing high blood pressure. Researchers are comparing results from healthy volunteers and patients suspected of having this condition to find the right cutoff numbers for the new test.
This trial looks for better ways to diagnose primary aldosteronism (PA), a common cause of high blood pressure that can be treated. It may help find people whose hypertension is caused by this condition so they can get the right treatment sooner.
This study tests if a 2-day version of the oral salt loading test works as well as the standard 3-day test to diagnose primary aldosteronism (a common cause of high blood pressure). If effective, it could make diagnosis faster and easier for patients.
This study looks at the genes and molecules in people with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone), primary hypertension (high blood pressure), and healthy volunteers. The goal is to better understand these conditions and find better ways to diagnose and treat them.
This study tests two new types of PET/MR scans (68Ga-Pentixafor and 68Ga-FAPI-04) to see if they can better detect the cause of primary aldosteronism — a condition that leads to hard-to-control high blood pressure. The scans may help doctors decide which treatment is best for you.
This trial tests whether a simple steroid-based test can help identify a specific type of high blood pressure called primary aldosteronism. If you have high blood pressure that needs medication, this study may help find a treatable cause.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.